July 2026
Explore the checkpoint inhibitor drugs market, driven by rising cancer prevalence, expanding indications for PD-1/PD-L1 and CTLA-4 inhibitors, and advancements in immuno-oncology therapies.
June 2026
The global checkpoint inhibitor biologics CDMO market is growing as demand rises for outsourced biologics development and scalable immuno-oncology manufacturing.
June 2026
The global PD-1 inhibitor drugs market size was estimated at USD 48.69 billion in 2025 and is expected to hit around USD 201.87 billion by 2035, growing at a CAGR of 15.28% from 2026 to 2035.
April 2026
The global immune checkpoint inhibitors market size is predicted to hit around USD 258.91 billion by 2035 from USD 58.53 billion in 2025 with a CAGR of 16.03%.
July 2025
The global lipase inhibitors obesity drugs market size was estimated at USD 1.25 billion in 2024 and is expected to hit around USD 4.94 billion by 2034, growing at a CAGR of 14.72%.
July 2025
The global tumor necrosis factor inhibitor drugs market size is projected to hit around USD 51.55 billion by 2034 from USD 42.86 billion in 2024 with a CAGR of 1.86%.
July 2026
The lyophilized injectable drugs market size was valued at USD 397.17 billion in 2025 and is expected to attain around USD 1,516.32 billion by 2035, with a CAGR of 14.34%.
July 2026
The asthma drugs market was valued at USD 26.49 billion in 2025 and is expected to hit around USD 42.74 billion by 2035, growing at a CAGR of 4.46% from 2026 to 2035.
July 2026
The global cardiovascular drugs market size is valued at USD 155.96 billion in 2025 and is expected to hit around USD 221.20 billion by 2035, growing at a CAGR of 3.56% from 2026 to 2035.
July 2026
The global cephalosporin drugs market size was calculated at USD 20.65 billion in 2025 and is projected to attain around USD 27.69 billion by 2035, with a CAGR of 2.98%.
July 2026
The global lipid-lowering drugs market size was evaluated at USD 35.46 billion in 2025 and is projected to attain around USD 49.65 billion by 2035 with a CAGR of 3.42%.
July 2026
The global oxycodone drugs market size was valued at USD 7.06 billion in 2025 and is projected to reach around USD 12.10 billion by 2035 with a CAGR of 5.54%.
July 2026
The global VMAT2 inhibitors market size was evaluated at USD 6.04 billion in 2025 and is predicted to hit around USD 15.29 billion by 2035, growing at a CAGR of 9.74%.
July 2026
The global generic drugs market size is estimated at USD 491.67 billion in 2026 and is projected to reach USD 762.48 billion by 2035 at a 5% CAGR, driven by rising demand for affordable medicines and patent-expired drugs.
July 2026
The global general anesthesia drugs market size was calculated at USD 5.60 billion in 2025 and is projected to surpass around USD 8.06 billion by 2035, with a CAGR of 3.71%.
July 2026
The U.S. pain management drugs market size was estimated at USD 32.79 billion in 2025 and is projected to hit around USD 46.50 billion by 2035, at a CAGR of 3.56%.
July 2026
The global 3D printed drugs market size was estimated at USD 338.28 million in 2024 and is predicted to reach around USD 789.20 million by 2034 with a CAGR of 8.84%.
July 2026
The psoriatic arthritis therapeutics drugs market is growing with rising demand for biologics, biosimilars, and advanced targeted treatment options.
July 2026
The global over the counter (OTC) drugs market size is expected to increase from USD 135.25 billion in 2025 and is expected to hit USD 256.87 billion by 2035, growing at a CAGR of 6.62%
July 2026
The global C5 complement inhibitors market size is estimated to hit around USD 17.83 billion by 2035 increasing from USD 4.85 billion in 2025, with a CAGR of 13.90%.
July 2026
The global immunotherapy drugs market size was valued at USD 318.83 billion in 2025 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
June 2026
The global epigenetic drugs market size is anticipated at USD 16.22 billion in 2025 and is predicted to hit around USD 92.57 billion by 2035, growing at a CAGR of 19.03%.
June 2026
The U.S. multiple sclerosis drugs market size is estimated to hit around USD 18.43 billion by 2035 increasing from USD 8.44 billion in 2025, with a CAGR of 8.12%.
June 2026
The global SGLT-2 inhibitors market size is estimated to hit around USD 33.11 billion by 2035 increasing from USD 18.18 billion in 2025, with a CAGR of 6.18%.
June 2026
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
June 2026
The global rheumatoid arthritis drugs market size was valued at USD 64.35 billion in 2025 and is expected to hit around USD 76.83 billion by 2035, growing at a CAGR of 1.79% from 2026 to 2035.
June 2026
The global leukemia inhibitory factor (LIF) market size is estimated to hit around USD 3.13 billion by 2035 increasing from USD 1.34 billion in 2025, with a CAGR of 8.85%.
June 2026
The global orphan drugs market size was surpass to USD 216.55 billion in 2025 and is projected to reach around USD 676.59 billion by 2035 with a CAGR of 12.07%.
June 2026
The global atherosclerosis drugs market size is projected to hit around USD 25.07 billion by 2035, increasing from USD 17.60 billion in 2025, with a CAGR of 3.60%.
June 2026
The global dermatology drugs market size was calculated at USD 23.86 billion in 2025 and is projected to hit around USD 69 billion by 2035 with a CAGR of 11.2% .
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com